https://www.selleckchem.com/pr....oducts/LDE225(NVP-LD
It causes significant protection against after i.p. injection. Profilin (as an adjuvant) in combination with TLA could be a potent vaccine candidate that evokes a powerful specific immune response and significantly improves the efficacy of TLA vaccine by increasing the induction of INF-γ production and by shifting the immune responses to Th1 profile through increasing the INF-γ/IL-5 ratio. It causes significant protection against T. gondii after i.p. injection. Strongyloidiasis is a public health concern in northern regions o
Like
Comment
Share
